Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 1998, p. 3059-3064, Vol. 42, No. 12
Division of Microbiology, Department of
Pharmaceutical Biosciences, Biomedical Center, Uppsala University,
S-751 23 Uppsala, Sweden
Received 12 March 1998/Returned for modification 29 May
1998/Accepted 9 September 1998
The pathogenic bacterium Campylobacter jejuni has been
regarded as endogenously resistant to trimethoprim. The genetic basis of this resistance was characterized in two collections of clinical isolates of C. jejuni obtained from two different parts of
Sweden. The majority of these isolates were found to carry foreign
dfr genes coding for resistant variants of the
dihydrofolate reductase enzyme, the target of trimethoprim. The
resistance genes, found on the chromosome, were dfr1 and
dfr9. In about 10% of the strains, the dfr1
and dfr9 genes occurred simultaneously. About 10% of the
examined isolates were found to be negative for these dfr genes and showed a markedly lower trimethoprim resistance level than
the other isolates. The dfr9 and dfr1 genes
were located in the context of remnants of a transposon and an
integron, respectively. Two different surroundings for the
dfr9 gene were characterized. One was identical to the
right-hand end of the transposon Tn5393, and in the other,
the dfr9 gene was flanked by only a few nucleotides of a
Tn5393 sequence. The insertion of the dfr9 gene
into the C. jejuni chromosome could have been mediated by
Tn5393. The frequent occurrence of high-level trimethoprim
resistance in clinical isolates of C. jejuni could be
related to the heavy exposure of food animals to antibacterial drugs,
which could lead to the acquisition of foreign resistance genes in
naturally transformable strains of C. jejuni.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
High-Level Resistance to Trimethoprim in Clinical
Isolates of Campylobacter jejuni by Acquisition of Foreign
Genes (dfr1 and dfr9) Expressing
Drug-Insensitive Dihydrofolate Reductases
*
Corresponding author. Mailing address: Division of
Microbiology, Department of Pharmaceutical Biosciences, P.O. Box 581, Biomedical Center, Uppsala University, S-751 23 Uppsala, Sweden. Phone:
46-18-4714500. Fax: 46-18-502790. E-mail:
ola.skold{at}farmbio.uu.se.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»